Evidence map›Paper›PMID 41022789›Full record

ArticleNature communications2025

Multivalent binding of the tardigrade Dsup protein to chromatin promotes yeast survival and longevity upon exposure to oxidative damage.

Rhiannon R Aguilar, Laiba F Khan, Christopher K Cummins, Nina Arslanovic, Thea Grauer, Kaylah Birmingham, Kritika Kasliwal, Spike D L Posnikoff, Ujani Chakraborty, Allison R Hickman and 14 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Tardigrade Dsup extendsScience advances · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Rhiannon R Aguilar *Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5723-608X
Laiba F Khan *EpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0009-0000-5427-0653
Christopher K CumminsDepartment of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nina ArslanovicDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Thea GrauerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Kaylah BirminghamDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Kritika KasliwalDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Spike D L PosnikoffDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Ujani ChakrabortyDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Allison R HickmanEpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0009-0007-7901-6687
Rachel WatsonEpiCypher Inc., Durham, NC, USA.
Ryan J EzellEpiCypher Inc., Durham, NC, USA.
Sabrina R HuntEpiCypher Inc., Durham, NC, USA.
Laylo MukhsinovaEpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0009-0008-7689-3497
Hannah E WillisEpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0009-0001-5996-2322
Martis W CowlesEpiCypher Inc., Durham, NC, USA.
Richard GarnerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Abraham ShimDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5351-0774
J Ignacio GutierrezDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-9017-8384
Bryan J VentersEpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0000-0002-4607-0587
Matthew R MarundeEpiCypher Inc., Durham, NC, USA.
Brian D StrahlDepartment of Biochemistry and Biophysics and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-4947-6259
Michael-Christopher KeoghEpiCypher Inc., Durham, NC, USA. mkeogh@epicypher.com.ORCID http://orcid.org/0000-0002-2219-8623
Jessica K TylerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. jet2021@med.cornell.edu.ORCID http://orcid.org/0000-0001-9765-1659

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Mechanisms of chromatin and transcriptional regulationR35GM126900 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian D Strahl · 2018 to 2026
$5.5M
Chromatin's Role in Repair of Radiation-induced Damage.R01CA095641 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2002 to 2023
$5.2M
NRSA in GeneticsT32GM135128 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Daniel J McKay, JEFF J. SEKELSKY · 2020 to 2026
$5.1M
Development of efficient quantitative chromatin profiling in kit and high-throughput formatsR44HG010640 · NHGRI · EPICYPHER, INC. · PI KEOGH, MICHAEL-CHRISTOPHER, VENTERS, BRYAN J · 2020 to 2022
$2.4M
Discovering how autophagy is sufficient to extend yeast replicative lifespan (SUPPLEMENT)R01AG079883 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jessica K Tyler · 2023 to 2026
$2.2M
Novel pathways that regulate DNA double-strand break repair events in mammalian cellsR35GM139816 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TYLER, JESSICA K · 2021 to 2025
$2.1M
Accelerated discovery of methylation targeted therapeutic developmentR44CA212733 · NCI · EPICYPHER, INC. · PI SUN, ZU-WEN · 2018 to 2019
$2.1M
Multiplex nucleosome-based profiling for the development of next-generation chromatin labeling reagentsR44GM136172 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2020 to 2021
$1.8M
High-throughput methyltransferase assays using recombinant nucleosome substratesR44GM117683 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2018 to 2019
$1.7M
NCI NIH HHS R01 CA095641NCI NIH HHS R44 CA212733NHGRI NIH HHS R44 HG010640NIA NIH HHS R01 AG079883NIGMS NIH HHS R35 GM126900NIGMS NIH HHS R35 GM139816NIGMS NIH HHS R44 GM117683NIGMS NIH HHS R44 GM136172NIGMS NIH HHS T32 GM007739NIGMS NIH HHS T32 GM135128U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01 CA95641
6 · The paper itself

Abstract

Tardigrades are remarkable in their ability to survive extreme environments. The damage suppressor (Dsup) protein is thought to contribute to their extreme resistance to reactive oxygen species (ROS) generated by irradiation. Here we show that expression of Ramazzottius varieornatus Dsup in Saccharomyces cerevisiae reduces oxidative DNA damage and extends lifespan in response to chronic oxidative genotoxicity. Dsup uses multiple modes of engagement with the nucleosomal H2A/H2B acidic patch, H3/H4 histone tails and DNA to bind across the yeast genome without bias. Effective chromatin binding and genome protection requires the Dsup HMGN-like motif and C-terminal sequences. These findings give precedent and mechanistic understanding for engineering an organism by physically shielding its genome to promote survival and longevity in the face of oxidative damage.

Indexed as

ChromatinOxidative StressSaccharomyces cerevisiaeTardigradaAnimalsDNA DamageHistonesLongevityNucleosomesProtein BindingReactive Oxygen SpeciesSaccharomyces cerevisiae ProteinsChromatinHistonesNucleosomesReactive Oxygen SpeciesSaccharomyces cerevisiae Proteins

Identifiers

PMID41022789
PMCPMC12480509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.